Sanjeev Krishan has been with Glenmark Pharmaceuticals since 2005 and currently serves as President of Glenmark Pharmaceuticals Inc.’s North American business with responsibility for overall operations in the region. Sanjeev is an established industry veteran with over 23 years of experience across the pharmaceutical supply chain.

Prior to joining Glenmark, Sanjeev worked for Dr. Reddy’s Laboratories and Reddy Cheminor Inc. holding positions with responsibility for managing of the active pharmaceutical ingredients, custom synthesis and generic finished dosage businesses.

Sanjeev holds a degree in Chemistry from Delhi University, received a Master of Sciences in Biotechnology from the Indian Institute of Technology – Roorkee and completed his Master of Business Administration in marketing and finance at the Symbiosis Institute – Pune.

Rajeev Sharma is Senior Vice President Finance and Chief Financial Officer at Glenmark Pharmaceuticals Inc., USA and is responsible for managing the finance function for the North America region. Rajeev has over 25 years of experience in finance and has worked at Glenmark since 2014.

Prior to Glenmark, Rajeev worked for Ranbaxy Laboratories where he held served positions of Division, Country and Regional finance heads

Rajeev holds a Bachelor’s Degree in Commerce from Delhi University and a post-graduate degree in Cost and Management Accounting from the Institute of Cost & Works Accountants of India.

Laura Lester is Senior Vice President and General Counsel with responsibility for all legal matters in the United States and the global IPM group. She joined Glenmark in October 2020 and has been working with pharmaceutical companies on legal and compliance issues for over 20 years.

Prior to joining Glenmark, Laura was in private practice in Washington DC at Arnold & Porter Kaye Scholer LLP from 2010 to 2020 and Arent Fox LLP from 1997 to 2010. She received a J.D. from Georgetown University Law Center and a B.A. in political science from the University of Missouri.

Dmitrey Kuznetsov is Senior Vice President and Head of Commercial Operations at Glenmark Pharmaceuticals Inc., USA and is responsible for streamlining and driving the commercial operations to deliver profitable and sustainable growth for Glenmark. Dmitrey brings over 25 years of pharmaceutical industry experience before joining Glenmark in 2020.

Over the course of his career, Dmitrey has held positions with increasing responsibility at Sun Pharmaceuticals, HD Smith, McKesson and Eli Lilly. His vast experience in the pharmaceutical industry has allowed his to build an expertise in pharmaceutical commercialization, strategic sourcing and supply chain management.

Dmitrey holds a Bachelor’s Degree in Pharmacy from St. Louis College of Pharmacy and a Master’s Degree in Business Administration from Washington University’s John M. Olin School of Business.

As Senior Vice President of Strategy, Portfolio and Business Development at Glenmark Pharmaceuticals Inc., USA, Vijay is responsible for managing Glenmark’s product portfolio in support of the company’s long term strategic plan.

Prior to joining Glenmark, Vijay worked for several leading generic drug manufacturers including Sun Pharmaceuticals, Aurobindo and Sandoz, where he held roles with increasing responsibility over RD, portfolio, business development, project management and global intellectual property. Vijay holds a doctorate in synthetic organic chemistry from the University of Delhi.

Erica Guthrie is Vice President and Chief Compliance Officer for Glenmark Pharmaceuticals Inc., USA with responsibility for the operations and direction of the company’s compliance strategy, including promoting a culture of compliance.

Prior to joining Glenmark, Erica was in private practice in Washington, DC at Arnold & Porter Kaye Scholer LLP, where she counseled clients across industries, including life sciences and healthcare. She received a Juris Doctor degree from American University Washington College of Law and a Bachelor of Arts in History and Political Science from Colgate University.